Bristol Myers Squibb CEO Chris Boerner sits down with CNBC's Angelica Peebles at the American Society of Clinical Oncology's ...
InvestorsHub on MSN
Bristol Myers Squibb wins EU green light for Opdivo-based Hodgkin lymphoma treatment (BMY)
Bristol Myers Squibb (NYSE:BMY) has secured approval from the European Commission for the use of Opdivo (nivolumab) in ...
Most Undervalued Stocks to Invest In. On May 20, 2026, Bristol-Myers Squibb Company (NYSE:BMY) announced a strategic ...
The latest medicines from Bristol Myers Squibb (BMY +0.47%) were the driving force behind the company's considerable share price gain on Thursday. The pharmaceutical company's fir ...
The numbers don't tell the full story with this big pharma stock.
Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) accepted a supplemental New Drug Application (sNDA) for Camzyos (mavacamten) as a potential treatment for ...
8d
Is Bristol-Myers Squibb (BMY) One of the Best Dividend Stocks to Invest in According to Hedge Funds?
With an annual dividend yield of 4.25%, Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Dividend Stocks ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The New Jersey-based ...
Houston Chronicle on MSN
Bristol Myers Squibb eyes Houston's Generation Park for $1B phama plant that could create 500 jobs
Houston is one of three sites the global pharma company is considering.
Bristol Myers Squibb came into the quarter with fairly modest expectations hanging over it. Instead, the company delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results